About Event

3rd mRNA-Based Therapeutics Summit - What's On?

With 200+ clinically active mRNA drugs and a further 500+ in preclinical development, the mRNA industry is expanding its horizons beyond COVID-19, driving their ambition to unlock mRNA platforms from proof-of-concept through to clinical validation for next generation mRNA therapeutics and vaccines. The 3rd mRNA-Based Therapeutics Summit returns as the community’s most comprehensive forum and a chance to come together and celebrate the field’s substantial progress, providing a roadmap for end-to-end mRNA drug development, advancing towards the clinic and delivering the promise of better mRNA medicines, to patients faster.

Hot Sessions for 2023:

Unlocking the next Generation of mRNA-based vaccines targeting infectious diseases with the FDA’s perspective
Discover how the development of Moderna’s candidate for mRNA-1345 RSV vaccine is taking shape for Older Adults after receiving FDA breakthrough designation
Unlock the next wave of mRNA therapeutics with a clinical update from BioNTech

What's New For 2023:

Attendees icon

500+ Attendees Large Pharma, Biotech & Academia

Speakers icon

100+ World-Class Speakers

arrows

10+ Hours of Dedicated In-Person Networking

Speakers icon

5 Dedicated Tracks of Content

cog

2 Pre-Conference Days

Attendees icon

1 Engaging Pre-Conference Workshop Day

Speakers icon

5 Interactive Panel Discussions

Snapshot of New Speaking Companies for 2023

BioNTech
FDA
Afrigen Biologics
Akagera Medicines
AstraZeneca
Ethris
Regeneron
Genentech
GSK
Merck
Gritstone Bio
Omega Therapeutics
Orbital Therapeutics
Pantherna
pHion Therapeuitcs

Preview the Event

Watch our event highlights video to find out what you can look forward to in 2023!

2023 Summit Overview

PRE-CONFERENCE FOCUS DAY: NEXT GENERATION mRNA-MEDIATED TECHNOLOGIES

  • Harness the power of mRNA for use in gene editing and cell therapy to expand disease targets and maximize therapeutic potential
  • Discover the future of programmable and switchable RNA tools, taking mRNA therapeutics to new heights
  • Insights from Exacis Biotherapeutics, Cartesian Therapeutics, Turn Biotechnologies, Strand Therapeutics and more

PRE-CONFERENCE WORKSHOP DAY

  • Broaden your insights into novel LNP formulations and beyond for next generation mRNA therapeutic and vaccine delivery
  • Explore the potential of circular RNA with improved design, stability and overcoming immunogenicity
  • Expand your analytical toolbox to include an arsenal of tests to ensure your mRNA products’ quality and consistency can meet the future regulatory standards
  • Insights from Tessera Therapeutics, Seqirus, Orbital Therapeutics, GlaxoSmithKline and more

MAIN CONFERENCE DAYS

DISCOVERY

  • Unlock next generation mRNA sequence optimization, from capping to poly-A tails to enhance chemical stability and protein expression
  • Unleash novel payload carriers from LNPs and beyond to enable successful tissue targeting and selectivity
  • Insights from ReCode Therapeutics, AstraZeneca, Nava Therapeutics, pHion • Unlock next generation mRNA sequence optimization, from capping to poly-A tails to enhance chemical stability and protein expression

TRANSLATION

  • Optimize your mRNA medicines using the most relevant in vitro and in vivo models for improved safety and efficacy
  • Explore the latest mRNA preclinical investigations into infectious diseases, oncology, lung and protein replacement therapies
  • Insights from Kernal Bio, Ethris, Elastrin Therapeutics, ARV Technologies and more

CLINICAL DEVELOPMENT

  • Unlock next generation mRNA sequence optimization, from capping to poly-A tails to enhance chemical stability and protein expression
  • Unleash novel payload carriers from LNPs and beyond to enable successful tissue targeting and selectivity
  • Insights from Moderna, Vertex Pharmaceuticals, Gritstone Bio, RVAC Medicines and more

CHEMISTRY, MANUFACTURING & CONTROLS (CMC)

  • Discover new tools for mRNA product development and analytical characterization to create the ultimate therapeutic
  • Elevate your mRNA drug product manufacturing and CMC processes at scale to accelerate drugs to market
  • Insights from BioNTech SE, Genentech, Omega Therapeutics, GeneLeap Biotech and more

LOGISTICS

  • Combat mRNA raw material, cold chain storage and bioproduction for an efficient supply chain
  • Expand mRNA vaccine and therapeutic global supply chains with equity, sustainability and cost effectiveness to LMICs
  • Insights from: Beam Therapeutics, Afrigen Biologics, CEPI, PATH and more
EVENT GUIDE
REGISTER
PARTNER